Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) Stock Analysis
DELISTED
What happened to Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) stock?
Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
P/E 2.39 means the share price is 2.39 times one year of earnings per share. Market cap $18.1B is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY). Taisho Pharmaceutical Holdings Co., Ltd. is a global pharmaceutical company based in Japan, focusing on both over-the-counter (OTC) and prescription drugs.
Last analyzed: Mar 16, 2026Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) Healthcare & Pipeline Overview
Taisho Pharmaceutical Holdings Co., Ltd. ADR Information Unsponsored
Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) trades in the U.S. as an American Depositary Receipt (ADR).
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: TAIP
TAIPY OTC Market Information
TAIPY trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy TAIPY shares?
No. TAIPY stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for TAIPY elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before TAIPY stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Taisho Pharmaceutical Holdings Co., Ltd.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.